Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:14 pm Sale | 2022-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Versor Investments LP | 0 0.000% | -5,018,146 (Position Closed) | Filing History |
| 2022-02-24 12:05 pm Purchase | 2022-02-14 | 13D | BioDelivery Sciences International, Inc. BDSI | Magnetar Financial LLC | 6,695,999 6.770% | 6,695,999 (New Position) | Filing History |
| 2022-02-24 11:06 am Purchase | 2022-02-14 | 13G | BioDelivery Sciences International, Inc. BDSI | Versor Investments LP | 5,018,146 5.080% | 5,018,146 (New Position) | Filing History |
| 2022-02-14 08:04 am Sale | 2021-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Nantahala Capital Management LLC | 0 0.000% | -5,123,671 (Position Closed) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | James E. Flynn | 29,204 0.030% | -9,500,796 (-99.69%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | BlackRock Inc. BLK | 7,305,512 7.400% | -909,129 (-11.07%) | Filing History |
| 2021-02-16 06:23 am Purchase | 2020-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Nantahala Capital Management LLC | 5,123,671 5.100% | 277,504 (+5.73%) | Filing History |
| 2021-02-12 12:26 pm Purchase | 2020-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | James E. Flynn | 9,530,000 9.430% | 2,984,500 (+45.60%) | Filing History |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | BlackRock Inc. BLK | 8,214,641 8.100% | 910,299 (+12.46%) | Filing History |
| 2020-04-06 08:00 am Purchase | 2020-03-25 | 13G | BioDelivery Sciences International, Inc. BDSI | James E. Flynn | 6,545,500 6.790% | 6,081,417 (+1310.42%) | Filing History |
| 2020-02-14 12:18 pm Purchase | 2019-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Nantahala Capital Management LLC | 4,846,167 5.400% | 4,846,167 (New Position) | Filing History |
| 2020-02-14 10:08 am Sale | 2019-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Avoro Capital Advisors LLC | 3,000,000 3.340% | -5,614,588 (-65.18%) | Filing History |
| 2020-02-13 4:27 pm Sale | 2019-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI | Stonepine Capital Management LLC | 0 0.000% | -3,981,867 (Position Closed) | Filing History |